Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals, explores the latest developments in Ukraine.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
Almost six years since the law change, children still struggle to access a consistent supply of medicine in the UK, writes Matt Hughes, Medcan Family Foundation.
Exploring the cutaneous Endocannabinoid System and its potential applications in treating various dermatological conditions.
A notable reduction in crystal meth use was observed among those who used cannabis for craving management.
Greece was among the first in Europe to legalise medical cannabis in 2017.
Spain’s Ministry of Health has launched a public consultation on its proposals for a medical cannabis framework in the country.
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
From 26th February, the medical cannabis division of Rokshaw Ltd is rebranding to Curaleaf Laboratories. Since its inception in 2012 by founders Jonathan and Richard Hodgson,...
High-quality cannabis on the medical market is the holy grail among both patients and clinics with heart. There’s still a fair bit of catching up to...
The IACM Patient Council will highlight the barriers facing cannabis patients across the globe in Vienna next month.